SFX by Ex Libris Inc.

Title:	Personalized medicine. Pushing the envelope in neuroblastoma therapy
Source:	Science [0036-8075] Couzin Frankel, J yr:2011

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Kaiser, J. "Personalized medicine. New cystic fibrosis drug offers hope, at a price." Science 335.6069 (2012): 645-645.
description	2.	Naik, S. "Towards personalized medicine - the role of methotrexate." Indian Journal of Medical Research 133.3 (2011): 253-255.
description	3.	Farrell, Philip M. "Transformative mutation specific pharmacotherapy for cystic fibrosis." BMJ. British medical journal 344 (2012).
description	4.	COUNIHAN, T. "IMMUNOSUPPRESSIVE THERAPY IN AUTOIMMUNE DISEASE A REVIEW." Irish journal of medical science 160.7 (1991): 199-205.
description	5.	Imamura, F. "Systematic review and meta-analysis of methotrexate use and risk of cardiovascular disease." The American journal of cardiology 108.9 (2011): 1362-70.
description	6.	McCreery, H. "Genetics & Genomics: What Every Oncology Nurse Needs to Know." ONS connect 26.2 (2011): 8-12.
description	7.	Woolf, Richard T. "How genetic variation affects patient response and outcome to therapy for psoriasis." Expert review of clinical immunology 6.6 (2010): 957-966.
description	8.	Shapley, R. "Vision: Gene therapy in colour." Nature 461.ISS 7265 (2009): 737-739.
description	9.	Katsanis,, S. H., H. "A Case Study of Personalized Medicine." Science 320.5872 (2008): 53-54.
description	10.	Davies, J. "Cystic fibrosis." BMJ british medical journal 335.7632 (2007): 1255-1259.
description	11.	Wicks, E. "Cystic fibrosis." BMJ 334.7606 (2007): 1270-1271.
description	12.	Bilton, D. "Cystic fibrosis." Medicine 36.5 (2008): 273-278.
description	13.	Ratjen, F. "Cystic fibrosis." The lancet 361.9358 (2003): 681-689.
description	14.	ROWE, STEVEN M. "Cystic Fibrosis." The New England journal of medicine 352.19 (2005): 1992-2001.
description	15.	Geddes, D. "Cystic fibrosis." Clinical medicine 7.5 (2007): 445-6.
description	16.	Amaral, M. "Molecular targeting of CFTR as a therapeutic approach to cystic fibrosis." Trends in Pharmacological Sciences 28.7 (2007): 334-341.
description	17.	Chen, Yi-Ju J. "Association between systemic anti-psoriatic drugs and cardiovascular risk in patients with psoriasis and psoriatic arthritis: A nationwide cohort study." Arthritis & rheumatism 64.6 (2011): 1879-1887.
description	18.	Brodlie, M. "Interleukin-17 and cystic fibrosis lung disease." American journal of respiratory and critical care medicine 185.1 (2012): 108-109.
description	19.	Davis, Pamela B. "Therapy for Cystic Fibrosis — The End of the Beginning?" The New England journal of medicine 365.18 (2011): 1734-1735.
description	20.	Ramsey, Bonnie W. "A CFTR potentiator in patients with cystic fibrosis and the G551D mutation." The New England journal of medicine 365.18 (2011): 1663-1672.